Skip to main content
Springer Nature Link
Log in

Evaluation of serum C-reactive protein, procalcitonin, tumor necrosis factor alpha, and interleukin-10 levels as diagnostic and prognostic parameters in patients with community-acquired sepsis, severe sepsis, and septic shock

  • Article
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

The diagnostic value of procalcitonin, C-reactive protein, tumor necrosis factor-alpha, and interleukin-10 levels in differentiating sepsis from severe sepsis and the prognostic value of these levels in predicting outcome were evaluated and compared in patients with community-acquired sepsis, severe sepsis, and septic shock in the first 72 h of admission to the hospital. Thirty-nine patients were included in the study. The severe sepsis and septic shock cases were combined in a single “severe sepsis” group, and all comparisons were made between the sepsis (n=21 patients) and the severe sepsis (n=18 patients) groups. Procalcitonin levels in the severe sepsis group were found to be significantly higher at all times of measurements within the first 72 h and were significantly higher at the 72nd hour in patients who died. Procalcitonin levels that remain elevated at the 72nd hour indicated a poor prognosis. C-reactive protein levels were not significantly different between the groups, nor were they indicative of prognosis. No significant differences in the levels of tumor necrosis factor-alpha were found between the sepsis and severe sepsis groups; however, levels were higher at the early stages (at admission and the 24th hour) in patients who died. Interleukin-10 levels were also higher in the severe sepsis group and significantly higher at all times of measurement in patients who died. When the diagnostic and prognostic values at admission were evaluated, procalcitonin and interleukin-10 levels were useful in discriminating between sepsis and severe sepsis, whereas tumor necrosis factor-alpha and interleukin-10 levels were useful in predicting which cases were likely to have a fatal outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C (1993) High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 341:515–518

    Article  PubMed  CAS  Google Scholar 

  2. Becker KL, Nylen ES, White JC, Müller B, Snider RH (2004) Procalcitonin and the calcitonin gene family of peptides in inflammation, infection and sepsis: a journey from calcitonin back to its precursors. J Clin Endocrinol Metab 89:1512–1525

    Article  PubMed  CAS  Google Scholar 

  3. van Rossum AM, Wulkan RW, Ousdesluys-Murphy AM (2004) Procalcitonin as an early marker of infection in neonates and children. Lanset Infect Dis 4:620–630

    Article  Google Scholar 

  4. Carrol ED, Thomson APJ, Hart CA (2002) Procalcitonin as a marker of sepsis. Int J Antimicrob Agents 20:1–9

    Article  PubMed  CAS  Google Scholar 

  5. Whicher J, Bienvenu J, Monneret G (2001) Procalcitonin as an acute phase marker. Ann Clin Biochem 38:483–493

    Article  PubMed  CAS  Google Scholar 

  6. Carlet J (1999) Rapid diagnostic methods in the detection of sepsis. Infect Dis Clin North Am 13:483–494

    Article  PubMed  CAS  Google Scholar 

  7. Gogos CA, Drosou E, Bassaris HP, Skoutelis A (2000) Pro-versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis 181:176–180

    Article  PubMed  CAS  Google Scholar 

  8. Schröder J, Staubach KH, Zabel P, Stüber F, Kremer B (1999) Procalcitonin as a marker of severity in septic shock. Langenbeck’s Arch Surg 384:33–38

    Article  Google Scholar 

  9. Balcı C, Sungurtekin H, Gürses E, Sungurtekin U, Kaptanoğlu B (2003) Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit. Crit Care 7:85–90

    Article  PubMed  Google Scholar 

  10. Harbarth S, Holeckova K, Froidevaux C, Pittet D, Ricou B, Grau GE (2001) Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. J Respir Crit Care Med 163:396–402

    Google Scholar 

  11. Ruokonen E, Nousiainen T, Pulkki K, Takala J (1999) Procalcitonin concentrations in patients with neutropenic fever. Eur J Clin Microbiol Infect Dis 18:283–285

    Article  PubMed  CAS  Google Scholar 

  12. Chiesa C, Pellegrini G, Panero A, Osborn JF, Signore F, Assumma M et al (2003) C-reactive protein, interleukin-6, and procalcitonin in the immediate postnatal period: influence of illness severity, risk status, antanatal and perinatal complication, and infection. Clin Chem 49:68–68

    Article  Google Scholar 

  13. Wunder C, Eichelbronner O, Roewer N (2004) Are IL-6, IL-10 and PCT plasma concentrations reliable for outcome prediction in severe sepsis? A comparison with APACHE III and SAPS II. Inflamm Res 53:158–163

    Article  PubMed  CAS  Google Scholar 

  14. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864–874

    Article  Google Scholar 

  15. Meisner M, Tschaikowsky K, Palmaers T, Schmidt J (1999) Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS. Crit Care 3:45–50

    Article  PubMed  Google Scholar 

  16. Müller B, Becker KL, Schachinger H, Rickenbacher PR, Huber PR, Zimmerli W et al (2000) Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 28:977–983

    Article  PubMed  Google Scholar 

  17. Clec’h C, Ferriere F, Karoubi P, Fosse JP, Cupa M, Hoang P et al (2004) Diagnostic and prognostic value of procalcitonin in patients with septic shock. Crit Care Med 32:1166–1169

    Article  PubMed  Google Scholar 

  18. Ruokonen E, Ilkka L, Niskanen M, Takala J (2002) Procalcitonin and neopterin as indicators of infection in critically ill patients. Acta Anaestesiol Scand 46:398–404

    Article  CAS  Google Scholar 

  19. Ugarte H, Silva E, Mercan D, De Mendonca A, Vincent J (1999) Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med 27:498–504

    Article  PubMed  CAS  Google Scholar 

  20. Müller B, Becker KL (2001) Procalcitonin: how a hormone became a marker and mediator of sepsis. Swiss Med Wkly 131:595–602

    PubMed  Google Scholar 

  21. Levy MM, Fink PM, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G (2003) 2001 SCCM/ESICM/ATS/SIS International sepsis definitions conference. Crit Care 31:1250–1256

    Article  Google Scholar 

  22. Monneret G, Finck ME, Venet F, Debard AL, Bohe J, Bienvenu J, Lepape A (2004) The anti-inflammatory response dominates after septic shock: association of low monocyte HLA-DR expression and high interleukin-10 concentration. Immunol Lett 95:193–198

    Article  PubMed  CAS  Google Scholar 

  23. Dinarello CA (1997) Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. Chest 112:321–329

    Article  Google Scholar 

  24. Stanilova SA, Karakolev ZT, Dimov GS, Dobreva ZG, Miteva LD, Slavov ES, Stefanov CS, Stanilov NS (2005) High interleukin 12 and low interleukin 10 production after in vitro stimulation detected in sepsis survivors. Intensive Care Med 31:401–407

    Article  PubMed  Google Scholar 

  25. Lowe PR, Galley HF, Abdel-Fattah A, Webster NR (2003) Influence of interleukin-10 polymorphisms on interleukin-10 expression and survival in critically ill patients. Crit Care Med 31:34–38

    Article  PubMed  CAS  Google Scholar 

  26. Loisa P, Rinne T, Laine S, Hurme M, Kaukinen S (2003) Anti-inflammatory cytokine response and the development of multiple organ failure in severe sepsis. Acta Anaesthesiol Scand 47:319–325

    Article  PubMed  CAS  Google Scholar 

  27. Al-Nawas B, Kammer I, Shah PM (1996) Procalcitonin in diagnosis of severe infections. Eur J Med Res 1:331–333

    PubMed  CAS  Google Scholar 

  28. Kotake Y, Moore DR, Vasquez-Walden A, Tabatabaie T, Sang H (2003) Antioxidant amplifies antibiotic protection in the cecal ligation and puncture model of microbial sepsis through interleukin-10 production. Shock 19:252–256

    Article  PubMed  CAS  Google Scholar 

  29. Manley MO, O’Riordan MA, Levine AD, Latifi SQ (2005) Interleukin 10 extends the effectiveness of standard therapy during late sepsis with serum interleukin 6 levels predicting outcome. Shock 23:521–526

    PubMed  CAS  Google Scholar 

  30. Latifi SQ, O’Riordan MA, Levine AD (2002) Interleukin-10 controls the onset of irreversible septic shock. Infect Immun 70:4441–4446

    Article  PubMed  CAS  Google Scholar 

  31. Kahlke V, Dohm C, Mees T, Brotzmann K, Schreiber S, Schroder J (2002) Early interleukin-10 treatment improves survival and enhances immune function only in males after hemorrhage and subsequent sepsis. Shock 18:24–28

    Article  PubMed  Google Scholar 

  32. Wunderink RG, Waterer GW (2003) Genetics of sepsis and pneumonia. Curr Opin Crit Care 9:384–389

    Article  PubMed  Google Scholar 

Download references

Acknowledgement

This study was supported by a grant from Uludag University (Scientific Research Project, grant no: T-2002/7).

Author information

Authors and Affiliations

  1. Faculty of Medicine, Microbiology and Infectious Diseases Department, Uludag University, Görükle, 16059, Bursa, Turkey

    Y. Heper, E. H. Akalın, R. Mıstık, O. Töre, G. Göral, B. Oral, F. Budak & S. Helvacı

  2. Faculty of Medicine, Biostatistics Department, Uludag University, Görükle, 16059, Bursa, Turkey

    S. Akgöz

Authors
  1. Y. Heper
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. E. H. Akalın
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. R. Mıstık
    View author publications

    You can also search for this author inPubMed Google Scholar

  4. S. Akgöz
    View author publications

    You can also search for this author inPubMed Google Scholar

  5. O. Töre
    View author publications

    You can also search for this author inPubMed Google Scholar

  6. G. Göral
    View author publications

    You can also search for this author inPubMed Google Scholar

  7. B. Oral
    View author publications

    You can also search for this author inPubMed Google Scholar

  8. F. Budak
    View author publications

    You can also search for this author inPubMed Google Scholar

  9. S. Helvacı
    View author publications

    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence to Y. Heper.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Heper, Y., Akalın, E.H., Mıstık, R. et al. Evaluation of serum C-reactive protein, procalcitonin, tumor necrosis factor alpha, and interleukin-10 levels as diagnostic and prognostic parameters in patients with community-acquired sepsis, severe sepsis, and septic shock. Eur J Clin Microbiol Infect Dis 25, 481–491 (2006). https://doi.org/10.1007/s10096-006-0168-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-006-0168-1

Keywords